EN
HI
Venmax Drugs And Pharmaceuticals share price chart
Venmax Drugs And Pharmaceuticals Share Key Metrics
Volume
16971.00
Market Cap
14.12 CR
LTQ@LTP
3@16.08
ATP
15.44
Var Margin
28.92 %
Circuit Range
12.87-19.29
Delivery %
78.57 %
Value
2.62 L
ASM/GSM
No
Market Lot
1
Summary
VENMAX stock price is ₹16.08 as of 22 Aug, 2026. The stock intraday movement has stayed between ₹14.10 and ₹17.19, while Venmax Drugs And Pharmaceuticals share price 52 week high low is ₹14.10 & ₹36.96.
In terms of trading activity, VENMAX share price has recorded a volume of 16,971 shares. The Venmax Drugs And Pharmaceuticals has a market cap of ₹8782930. The stock’s Average Traded Price (ATP) stands at ₹15.44, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3 @ ₹16.08.
The Venmax Drugs And Pharmaceuticals upper circuit limit is ₹19.29 & The Venmax Drugs And Pharmaceuticals lower circuit limit is ₹12.87, with a Value of ₹2.62 L. The Delivery Percentage for the day is 78.57%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Venmax Drugs And Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
68.51
Sector P/B
3.35
Sec. Div. Yield
0.51
Venmax Drugs And Pharmaceuticals Resistance and Support
Pivot 16.82
Resistance
First Resistance
17.37
Second Resistance
18.15
Third Resistance
18.7
Support
First Support
16.04
Second Support
15.49
Third Support
14.71
Venmax Drugs And Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 21 2026 | 16.9 | 16.08 | -2.96% | 17.19 | 14.1 |
| Thu Aug 20 2026 | 17.04 | 16.57 | -4.72% | 17.6 | 16.27 |
| Wed Aug 19 2026 | 17.89 | 17.39 | 4.01% | 17.89 | 16.2 |
Venmax Drugs And Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-02-07 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-09-02 | Amalgamation & A.G.M. |
| 2025-08-16 | Others |
| 2025-07-23 | Quarterly Results |
| 2025-05-09 | Audited Results |
| 2025-02-08 | Quarterly Results |
| 2025-01-11 | Preferential issue of shares |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Venmax Drugs And Pharmaceuticals News
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026.
Venmax Drugs board approved Q1 FY27 results, reporting a profit of ₹11.66 lakhs (up 211.76% YoY) and revenue of ₹2.48 crores (up 104.75% YoY). Additionally, 7.8 lakh partly paid convertible share warrants were forfeited, retaining ₹39.01 lakhs for the company.
Aug 07 2026 16:56:05
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
Venmax Drugs & Pharmaceuticals board will convene on August 7, 2026. The agenda includes considering Q1 FY27 unaudited financial results and approving the forfeiture of partly paid-up share warrants.
Aug 01 2026 15:41:51
Read More
Venmax Drugs And Pharmaceuticals Management
| Name | Position |
|---|---|
| Priyanka Agarwal | Company Secretary & Compliance Officer |
| Venkata Rao Sadhanala | Whole Time Director |
Venmax Drugs And Pharmaceuticals Similar Stocks
Venmax Drugs And Pharmaceuticals FAQs
The Buying Price of Venmax Drugs And Pharmaceuticals share is 16.08 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Venmax Drugs And Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Venmax Drugs And Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Venmax Drugs And Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Venmax Drugs And Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Venmax Drugs And Pharmaceuticals’s valuation compare Sector P/E, P/B which are 68.51 & 3.35 with sector averages, along with growth rates and financial metrics.
The Market Cap of Venmax Drugs And Pharmaceuticals is 14.12 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Venmax Drugs And Pharmaceuticals share price is 36.96 & 14.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Venmax Drugs And Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
